Detalles de la búsqueda
1.
Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial.
Am J Transplant
; 17(6): 1594-1605, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27873477
2.
Oesophageal Doppler guided goal-directed haemodynamic therapy in thoracic surgery - a single centre randomized parallel-arm trial.
Br J Anaesth
; 118(6): 852-861, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575331
3.
[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis]. / Differenzialdiagnose myelproliferativer Neoplasien. Quantitative NF-E2-Immunhistochemie zur Unterscheidung zwischen essenzieller Thrombozythämie und primärer Myelofibrose.
Pathologe
; 34 Suppl 2: 201-9, 2013 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-24196613
4.
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects.
Int J Clin Pharmacol Ther
; 44(11): 572-9, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17176624
5.
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Br J Pharmacol
; 124(6): 1083-90, 1998 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-9720777
6.
Comparison of the ECL-cell frequency in the stomachs of 3 different rat strains.
Pathol Res Pract
; 188(4-5): 672-5, 1992 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-1409110
7.
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.
Int J Clin Pharmacol Ther
; 32(7): 323-8, 1994 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7952792
8.
Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.
Int J Clin Pharmacol Ther
; 32(7): 376-8, 1994 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7952801
9.
Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration.
Int J Clin Pharmacol Ther
; 39(6): 259-64, 2001 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-11430634
10.
Reference tables for the intrasubject coefficient of variation in bioequivalence studies.
Int J Clin Pharmacol Ther
; 33(8): 427-30, 1995 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8556220
11.
Characterisation of the rat lung lavage model as biological assay for testing the activity of surfactant preparations.
J Pharm Biomed Anal
; 20(1-2): 225-39, 1999 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10704027
12.
Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
Exp Toxicol Pathol
; 51(6): 495-505, 1999 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-10661808
13.
STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
Oncogene
; 33(25): 3256-66, 2014 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23912451
14.
Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
Neuromuscul Disord
; 24(2): 134-42, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24300782
15.
Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma.
J Clin Pathol
; 65(1): 29-35, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22011448
16.
Controversies in bioequivalence studies.
Clin Pharmacokinet
; 22(4): 247-53, 1992 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1606785
17.
Comment on: Updates of bioequivalence programs (including statistical power approximated by Student's t)
Comput Methods Programs Biomed
; 47(1): 93-4, 1995 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-7554866
18.
[Biometrical methods for the proof of efficacy in regulatory submissions. Non-inferiority in clinical studies]. / Biometrische Verfahren zum Wirksamkeitsnachweis im Zulassungsverfahren Nicht-Unterlegenheit in klinischen Studien.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 48(5): 562-71, 2005 May.
Artículo
en Alemán
| MEDLINE | ID: mdl-15887067
19.
Approximate sample sizes for testing hypotheses about the ratio and difference of two means.
J Biopharm Stat
; 9(4): 641-50, 1999 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-10576408
20.
The U.S. draft guidance regarding population and individual bioequivalence approaches: comments by a research-based pharmaceutical company.
Stat Med
; 19(20): 2769-74, 2000 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-11033574